Form 4 CRISPR Therapeutics AG For: 24 September

CRISPR Therapeutics AG General Counsel and Secretary James R. Kasinger exercised options covering 10,400 common shares on September 22, 2026, at an exercise price of $13.62 per share, acquired 10,400 shares, and sold 10…

Read more →

Fed Chair Warsh Delivers a Fresh, Clear Perspective

Economic data was a bit lighter this past week, but the new Fed chair held his first meeting and offered plenty to unpack on the health of the economy and future interest rate policy. As such, this edition of the Weekly…

Read more →